Impairment of proteasome structure and function in aging - PubMed (original) (raw)
Review
Impairment of proteasome structure and function in aging
Géraldine Carrard et al. Int J Biochem Cell Biol. 2002 Nov.
Abstract
Damage to macromolecules, and in particular protein, implicated in the cellular degeneration that occurs during the aging process, is corroborated by the accumulation of oxidative end-products over time. Oxidized protein build up is commonly seen as a hallmark of cellular aging. Protein turnover is essential to preserve cell function and the main proteolytic system in charge of cytosolic protein degradation is the proteasome. The proteasome is a multi-catalytic proteolytic complex, which recognizes and selectively degrades oxidatively damaged and ubiquitinated proteins. One of the hypothesis put forward to explain the accumulation of altered proteins is the decrease of proteasome activity with age. Indeed, accumulation of altered protein can be explained by increased protein alteration, decreased protein degradation or the combination of both. A short description of proteasome structure and of its role in cellular functions is first given. Then, accumulation of damaged protein is presented with emphasis on the pathways implicated in the formation of altered proteins. Finally, evidence for an age-related impairment of proteasome structure and function that has been reported by different groups is provided in the light of proteasomal dysfunction induced upon oxidative stress. It is now clear that proteasome activity is declining with age and that the loss in proteasome activity during aging is dependent of at least three different mechanisms: decreased proteasome expression; alterations and/or replacement of proteasome subunits and formation of inhibitory cross-linked proteins. However, it is also clear that events leading to the age- and disease-related loss of proteasome function have not yet been fully characterized.
Similar articles
- Protein degradation by the proteasome and its implications in aging.
Friguet B, Bulteau AL, Chondrogianni N, Conconi M, Petropoulos I. Friguet B, et al. Ann N Y Acad Sci. 2000 Jun;908:143-54. doi: 10.1111/j.1749-6632.2000.tb06643.x. Ann N Y Acad Sci. 2000. PMID: 10911955 Review. - Degradation of oxidized proteins by the 20S proteasome.
Davies KJ. Davies KJ. Biochimie. 2001 Mar-Apr;83(3-4):301-10. doi: 10.1016/s0300-9084(01)01250-0. Biochimie. 2001. PMID: 11295490 Review. - Protein repair and degradation during aging.
Friguet B. Friguet B. ScientificWorldJournal. 2002 Jan 29;2:248-54. doi: 10.1100/tsw.2002.98. ScientificWorldJournal. 2002. PMID: 12806056 Free PMC article. Review. - Protein turnover by the proteasome in aging and disease.
Shringarpure R, Davies KJ. Shringarpure R, et al. Free Radic Biol Med. 2002 Jun 1;32(11):1084-9. doi: 10.1016/s0891-5849(02)00824-9. Free Radic Biol Med. 2002. PMID: 12031893 Review. - Age-related alterations of proteasome structure and function in aging epidermis.
Bulteau AL, Petropoulos I, Friguet B. Bulteau AL, et al. Exp Gerontol. 2000 Sep;35(6-7):767-77. doi: 10.1016/s0531-5565(00)00136-4. Exp Gerontol. 2000. PMID: 11053667
Cited by
- Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets.
Thellung S, Corsaro A, Dellacasagrande I, Nizzari M, Zambito M, Florio T. Thellung S, et al. Front Neurosci. 2022 Sep 6;16:966019. doi: 10.3389/fnins.2022.966019. eCollection 2022. Front Neurosci. 2022. PMID: 36148145 Free PMC article. Review. - Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.
Raynes R, Pomatto LC, Davies KJ. Raynes R, et al. Mol Aspects Med. 2016 Aug;50:41-55. doi: 10.1016/j.mam.2016.05.001. Epub 2016 May 4. Mol Aspects Med. 2016. PMID: 27155164 Free PMC article. Review. - Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms.
Hurvitz N, Elkhateeb N, Sigawi T, Rinsky-Halivni L, Ilan Y. Hurvitz N, et al. Front Aging. 2022 Dec 14;3:1044038. doi: 10.3389/fragi.2022.1044038. eCollection 2022. Front Aging. 2022. PMID: 36589143 Free PMC article. Review. - The role of the proteasome in heart disease.
Li YF, Wang X. Li YF, et al. Biochim Biophys Acta. 2011 Feb;1809(2):141-9. doi: 10.1016/j.bbagrm.2010.09.001. Epub 2010 Sep 15. Biochim Biophys Acta. 2011. PMID: 20840877 Free PMC article. Review. - N-terminal acetylation and replicative age affect proteasome localization and cell fitness during aging.
van Deventer S, Menendez-Benito V, van Leeuwen F, Neefjes J. van Deventer S, et al. J Cell Sci. 2015 Jan 1;128(1):109-17. doi: 10.1242/jcs.157354. Epub 2014 Nov 20. J Cell Sci. 2015. PMID: 25413350 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical